[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery...

[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug...

New independent directors Christof Bircher and Nneka Ukpai bring significant expertise in business strategy, corporate finance and...

NEW YORK, NY / ACCESSWIRE / January 7, 2024 /  Laxxon Medical, a leading pharma-technology company pioneering a new generation of...

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Laxxon Medical Corp., a leading pharma technology platform company focusing on oral drug...

Laxxon is seeking out-licensing opportunities for lead asset LXM.2, or co-developments projects with 3DSP platform technology SPID® at...

NEW YORK, NY / ACCESSWIRE / October 9, 2024 /  Laxxon Medical , a US-based pharma-technology company pioneering a new generation of...

The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP fa

Learn more about Laxxon Medical's groundbreaking 3D printed oral GLP-1 asset, offering an alternative to injections in obesity treatments.

Laxxon Medical announced its participation in the 2024 BIO International Convention, to showcase its LXM.2 asset to potential partners.

Join Dr.Catherine Gatza, our VP of Regulatory Affairs, at the World Orphan Drug Congress USA 2024, in Boston, Massachusetts.

Laxxon Medical, a pioneering pharma-technology company, is set to participate in the 23rd Annual Needham Virtual Health Conference.

Discover how Laxxon Medical's patent for the sequential release of multiple drugs in pharmaceutical dosage forms revolutionizes healthcare.

Discover the groundbreaking pharmaceutical advancements of Laxxon Medical at the 26th Annual Needham Growth Conference.

Laxxon Medical announced its attending the 42nd Annual J.P. Morgan Healthcare Conference, the industry's largest healthcare symposium.

Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company's inaugural globalization venture.

Laxxon Medical announced its participation in the 29th annual BIO-Europe Convention, taking place November 6-8, 2023, in Munich, Germany.

Laxxon Medical announced today their strategic partnership with CU Innovations at the University of Colorado Anschutz Medical Campus.

Quick Response (QR) codes have shown enormous potential to improve the flow of information from industry to providers and patients by...

Laxxon Medical to Participate in 2023 BIO International Convention